← Browse by Condition
Medical Condition

osteoarthritis hip

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for osteoarthritis hip sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — osteoarthritis hip Clinical Trials

How many clinical trials are currently recruiting for osteoarthritis hip?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for osteoarthritis hip, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteoarthritis hip?
osteoarthritis hip research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteoarthritis hip clinical trial?
Eligibility criteria for osteoarthritis hip trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Bezirkskrankenhaus St. Johann in Tirol 1 trial
Embody Orthopaedic Limited 1 trial
University of British Columbia 1 trial
Uppsala University 1 trial
Imelda Hospital, Bonheiden 1 trial

Recruiting Clinical Trials

NCT05734651
Recruiting
PROMIS Evaluation Study
Enrollment
200 pts
Location
Austria
Sponsor
Bezirkskrankenhaus St. Johann ...
View Trial →
NCT06162195
Recruiting
The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
Enrollment
200 pts
Location
United Kingdom
Sponsor
Embody Orthopaedic Limited
View Trial →
NCT07069179
Recruiting
Feasibility of Choose to Move Replacement Ready
Enrollment
60 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT06145516
Recruiting
Promoting Sleep to Alleviate Pain - Arthroplasty
Enrollment
100 pts
Location
Sweden
Sponsor
Uppsala University
View Trial →
NCT05246813
Recruiting
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Enrollment
24 pts
Location
Belgium
Sponsor
Imelda Hospital, Bonheiden
View Trial →

Related Conditions

hip arthropathy (1) perthes disease (1) osteonecrosis (1) femoral neck fractures (1) inflammatory arthritis (1) osteoarthritis (1) osteoarthritis oa of the knee (1) total knee arthroplasty total hip arthroplasty (1) mobility limitation (1) social isolation or loneliness (1) pain (1) implementation science (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology